BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Sunday, May 12, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 17, 2017
View Archived Issues
Codexis enters protein engineering platform collaboration with Nestle Health Science
Read More
IDRI announces first-in-human study of leprosy vaccine candidate LepVax
Read More
Flex Pharma begins phase II study of FLX-787
Read More
Cognition Therapeutics' CT-1812 awarded FDA fast track designation
Read More
CELESTIAL study of cabozantinib meets primary endpoint, FDA grants priority review for untreated RCC
Read More
First study in infants conducted for MEDI-8897, phase II study underway
Read More
Philogen cleared by FDA to conduct phase III Daromun registration trial
Read More
NIAID presents phase II data for two Ebola vaccines
Read More
Inovio Pharmaceuticals commences phase Ib/II combination study in bladder cancer
Read More
Aimmune Therapeutics enters clinical collaboration with Sanofi and Regeneron
Read More
Dicerna Pharmaceuticals seeks to conduct phase I study of DCR-PHXC in U.K.
Read More
FDA clears ImmunoGen's IND for phase I study of IMGN-632
Read More
Aeglea BioTherapeutics, Merck & Co. to evaluate AEB-1102 with pembrolizumab in SCLC
Read More
Engineered replication-defective cytomegalovirus vaccine V-160 immunogenic in phase I study
Read More
Cara Therapeutics planning phase III pivotal program for CR-845
Read More
Jiangsu Chia Tai Tianqing Pharmaceutical and collaborators patent mutant IDH1 inhibitors
Read More
Cerveau Technologies, Janssen enter [18F]MK-6240 research agreement
Read More
Novel SERDs discovered by Medshine Discovery, Shandong Luoxin Pharmacy Group Co.
Read More
Johns Hopkins presents novel drug conjugates inhibiting glutamate carboxypeptidase 2
Read More
Amgen and Boston Children's Hospital collaborate to identify novel pain targets
Read More
FDA grants priority review to Imfinzi sBLA for locally advanced unresectable NSCLC
Read More
Mouse model of Phelan-McDermid syndrome developed
Read More
Halozyme begins study of PEGPH20 with atezolizumab
Read More
Abeona Therapeutics receives grants from Sanfilippo syndrome foundations
Read More
IGeneX launches three new tests for Lyme disease and tick-borne relapsing fever
Read More